Skip to content

Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey

Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey - Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050349
Enrollment
691
Registered
2023-03-01
Start date
2022-12-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

None listed

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Health insurance union members (approximately 600,000) who have agreed to secondary use of medical data contracted by DeSC, who are 19 to 75 years old, and who are health promotion support service app kencom provided by DeSC for health insurance unions 150,000 registrants (about 150,000) were assessed as having migraine (including suspected migraine) based on the ICHD-3 questionnaire. group

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
MS-QOL(Migraine-Specific Quality of Life)

Secondary

MeasureTime frame
WPAI(Work Productivity and Activity Impairment)

Countries

Japan

Contacts

Public Contacthiromi sano

Otsuka Pharmaceuticals Co., Ltd Medical Affairs Department

sanoh@otsuka.jp06-6943-7722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026